Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
(Politico) We need to get lifesaving aid to millions trapped behind Ukraine’s front lines
25/02/2023. Building on the success of the Black Sea grain deal, the UN should seize every opportunity to engage in humanitarian negotiations with Kyiv and Moscow.
Modify the humanitarian funding streams
03/17/2016. UN aid panel calls for ‘grand bargain’ on finance
Saving lives and staying alive
03/31/2016. MSF’s reflections on the phenomenon will be required reading
